The Asia Pacific wound care market is expected to grow from US$ 3,974.65 million in 2022 to US$ 5,776.72 million by 2028. It is estimated to record a CAGR of 6.4% from 2022 to 2028.
Rising Prevalence of Chronic Diseases and Related Wounds Fuels Asia Pacific Wound Care Market Growth
Chronic diseases such as diabetes, cancer, and other autoimmune disorders directly impact the body's natural healing ability. Diabetes and immunodeficiency conditions are among the most detrimental conditions that can slow down the speed of the wound repair process. Diabetes is the most identified chronic disease. The disease adversely impacts the immune system, which can complicate wound healing. The hyperglycemic environment promotes the formation of biofilms and makes diabetic wounds difficult to treat. The prolonged healing process due to chronic diseases leads to a long-term need for wound dressings, resulting in high demand for them. Moreover, the increased prevalence of cancer has fueled the number of interventions performed. As a result, wound dressings are often used to prevent postoperative wound infections. Most surgical wounds after cancer surgery are large and deep, resulting in exudate that requires frequent management. Advanced wound dressings such as hydrogels, alginates, and foams help in wound management and infection prevention. As a result, the rise in the prevalence of chronic diseases is propelling the demand for wound care products, fueling the Asia Pacific wound care market.
Asia Pacific Wound Care Market Overview
The Asia Pacific wound care market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. China dominated the market in 2022. The wound care market in China is expanding due to the country's high manufacturing and export capabilities. According to the Institute for Health Metrics and Evaluation (IHME), road injuries are the fifth leading cause of death, and diabetes ranks ninth. Road injuries and diabetes prevalence may cause chronic wounds requiring wound care in the long term. China has a high prevalence of diabetes, which is propelling the demand for wound care management to reduce the risk of slow-healing wounds in diabetic patients. As ulceration of the foot in diabetes is common and disabling and frequently leads to amputation of the leg. In 2021, International Diabetes Federation (IDF) reported that the number of diabetic cases reported in China in 2021 was 140.9 million, which accounts for 10.6% of China’s population, and this number is expected to reach 164.06 million by 2030. The report also quoted that the country reported about 72.83 million undiagnosed cases of diabetes in 2021. The chances of chronic wounds, especially foot ulcers, are high among the diabetic population. Thus, high cases of diabetes can increase the cases of diabetic foot ulcers, thereby increasing the demand for diabetic foot care management in China.
Asia Pacific Wound Care Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Wound Care Market Segmentation
The Asia Pacific wound care market is segmented based on product, wound type, end user, and country.
Based on product, the Asia Pacific wound care market is segmented into advanced wound dressing, surgical wound care, traditional wound care, and wound therapy devices. The advanced wound dressing segment held the largest share of Asia Pacific wound care market in 2022.
Based on wound type, the Asia Pacific wound care market is bifurcated into chronic wounds and acute wounds. The chronic wounds segment a larger share of the Asia Pacific wound care market in 2022.
Based on end user, the Asia Pacific wound care market is segmented into hospitals, specialty clinics, home healthcare, and others. The hospitals segment held the largest share of the Asia Pacific wound care market in 2022.
Based on country, the Asia Pacific wound care market has been categorized into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that China dominated the Asia Pacific wound care market in 2022.
3M Co, Baxter International Inc, Coloplast AS, ConvaTec Group Plc, Ethicon USA LLC, Integra LifeSciences Holdings Corp, Medtronic Plc, MiMedx, PAUL HARTMANN AG, and Smith & Nephew Plc are the leading companies operating in the Asia Pacific wound care market.